Mirabella Financial Services’s Vir Biotechnology VIR Stock Holding History

Mirabella Financial Services’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-16,856	Closed	-$151K	–	1167
2026 Q1	$151K	Buy	+16,856	New	+$134K	0.01%	820
2023 Q3	–	Sell	-412,008	Closed	-$10.1M	–	635
2023 Q2	$10.1M	Buy	+412,008	New	+$10.3M	1.11%	11
2022 Q2	–	Sell	-61,137	Closed	-$1.57M	–	726
2022 Q1	$1.57M	Buy	+61,137	New	+$1.81M	0.17%	116
2020 Q4	–	Sell	-29,130	Closed	-$1M	–	492
2020 Q3	$1M	Buy	+29,130	New	+$1.25M	0.14%	87

Other funds holding VIR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GSK plc London $602M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Mirabella Financial Services's VIR Position: Q2 2026 in Review

Mirabella Financial Services sold out of Vir Biotechnology (VIR) in Q2 2026, closing a stake of 16,856 shares — an estimated $151K sold.

Mirabella Financial Services first reported a position in VIR in Q3 2020 and held it in 4 quarters. The position peaked at $10.1M in Q2 2023. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

Mirabella Financial Services reported no remaining Vir Biotechnology position as of Q2 2026 after selling out during the quarter.
Mirabella Financial Services sold 16,856 Vir Biotechnology shares in Q2 2026, an estimated $151K.
Mirabella Financial Services first reported a position in Vir Biotechnology in Q3 2020 and held it in 4 quarters.
Mirabella Financial Services's Vir Biotechnology position peaked at $10.1M in Q2 2023.
237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Mirabella Financial Services's 13F filing for Q2 2026, filed 31 Jul 2026.